nPhase, Inc. raised US$30 million in Series D funding. Viking Global Investors led the round. The Florida-based company sells an AI-native clinical data platform for life sciences organizations.
Funding history
The round is nPhase's first equity raise since 2017. It grew for nearly a decade without any new equity financing. Viking Global Investors manages more than US$54 billion in capital across public and private investments.
Company scope
nPhase is based in Atlantic Beach, Florida. It serves pharmaceutical sponsors and contract research organizations. Its REDCap Cloud EDC product supports smaller sponsors, nonprofit groups, and academic researchers.
Platform capabilities
The nPhase.ai platform unifies its Unified Data Management System and Statistical Computing Environment. It connects clinical data from study startup through regulatory submission. Autonomous AI agents handle repetitive operational tasks while human experts keep decision authority.
The funding will support expansion of agentic AI capabilities. nPhase also plans to grow its enterprise clinical data business. The company aims to help life sciences teams use intelligent workflows.